RedHill Biopharma Advancing Opaganib Options For Ebola Virus Disease Outbreak

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

RedHill-Biopharma

More Like This

Biotech company Eradivir is developing lead drug EV25 to treat influenza

ViiV Healthcare to present data for its next generation of ultra long-acting treatments for HIV

PR Newswire associated0

Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection

Innovative Molecules Expands Virology Pipeline with Novel EBV Antiviral Program

Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development

Electron microscope image of BK virus, showing the VP1 capsid protein that creates an icosahedral shell around the viral genome.

Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program

ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026

PR Newswire associated0

Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease